hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

You are being redirected to the story the piece of content is found in so you can read it in context. Please click the following link if you are not automatically redirected within a couple seconds:

Johnson & Johnson takes heat from Doctors Without Borders for not sharing HIV drug patents [USA]

Author: Susan Todd, Star Ledger [USA], Published on: 25 April 2011

Doctors without Borders criticized Johnson & Johnson today for refusing to make patents on three HIV drugs available to a program that would reduce the cost of the medicines in developing countries…"Johnson & Johnson…has chosen to turn its back on these patients’’ [said Sophie Delaunay, a spokeswoman for Doctors Without Borders]. In an e-mail today, the New Brunswick-based healthcare giant said it preferred to provide access to its compounds through agreements with generic manufacturers. One of its latest agreements was announced in February…

Read the full post here

Related companies: Johnson & Johnson Tibotec (part of Johnson & Johnson)